UOC
BHC icon

UBS O'Connor’s Bausch Health BHC Stock Holding History

UBS O'Connor’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-39,664
Closed -$1.09M – 25
2021
Q4 		$1.09M Sell
39,664
-35,336
-47% -$946K 0.01% 646
2021
Q3 		$2.09M Sell
75,000
-90,000
-55% -$2.55M 0.02% 536
2021
Q2 		$4.84M Buy
+165,000
New +$5M 0.04% 281

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return

UBS O'Connor's BHC Position: Q1 2022 in Review

UBS O'Connor sold out of Bausch Health (BHC) in Q1 2022, closing a stake of 39,664 shares — an estimated $1.09M sold.

UBS O'Connor first reported a position in BHC in Q2 2021 and held it in 3 quarters. The position peaked at $4.84M in Q2 2021. 370 funds tracked by Wall St. Rank hold BHC as of Q1 2022.

  • UBS O'Connor reported no remaining Bausch Health position as of Q1 2022 after selling out during the quarter.
  • UBS O'Connor sold 39,664 Bausch Health shares in Q1 2022, an estimated $1.09M.
  • UBS O'Connor first reported a position in Bausch Health in Q2 2021 and held it in 3 quarters.
  • UBS O'Connor's Bausch Health position peaked at $4.84M in Q2 2021.
  • 370 funds tracked by Wall St. Rank held Bausch Health as of Q1 2022.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.